A-TRAIN
Unknown
506 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
CHANCES
Phase 1 Unknown
27 enrolled
VUBAR
Phase 2 Unknown
55 enrolled
OPTI-DOSE
Phase 4 Unknown
30 enrolled
UPLIFT
Phase NA Unknown
210 enrolled
AMT-151 in Patients With Selected Advanced Solid Tumours
Phase 1 Unknown
30 enrolled
RESTORE
Phase NA Unknown
352 enrolled
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Unknown
200 enrolled
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
Unknown
3,000 enrolled
Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy
Phase NA Unknown
196 enrolled
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
60 enrolled
A Study Evaluating MM-310 in Patients With Solid Tumors
Phase 1 Unknown
34 enrolled
E3N
Unknown
100,000 enrolled
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
Phase 1/2 Unknown
100 enrolled
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Phase 1 Unknown
20 enrolled
Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Phase 1/2 Unknown
60 enrolled
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Phase 1/2 Unknown
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Phase NA Unknown
2,200 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer
Phase 1 Unknown
30 enrolled
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
Phase 2 Unknown
24 enrolled
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer
Phase 2 Unknown
34 enrolled
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
Unknown
200 enrolled